OncoRes Medical key facts
as of Oct 2026- Developer of an intraoperative imaging tool designed to upgrade the standard of care in breast cancer surgery.
- OncoRes Medical is valued at approximately $24.1M as of Oct 2026 (last reported valuation).
- It has raised $40.0M; the latest was Later Stage VC ($18.6M) in Feb 2026.
- Notable investors include MedTech Innovator, Texas Medical Center, Brandon Capital, ANDHealth, Government of Western Australia — 19 tracked in total.
- Status: Privately Held (backing).
OncoRes Medical's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 19 names
- ·Watch OncoRes Medical: the Monday email on marks, rounds and moves
OncoRes Medical funding rounds
No funding rounds for OncoRes Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs OncoRes Medical
19+Membership and data by Private Market View
OncoRes Medical valuation
OncoRes Medical's last reported valuation was $24.1 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
OncoRes Medical investors
19 investors are on record for OncoRes Medical, including MedTech Innovator, Texas Medical Center, Brandon Capital and ANDHealth.
About OncoRes Medical
Developer of an intraoperative imaging tool designed to upgrade the standard of care in breast cancer surgery. The company's technology utilizes a novel combination of optical coherence tomography imaging, improving surgical accuracy and reducing complication rates and intraoperative complications, enabling surgeons to identify a tumor and healthy tissue.
- Sector
- Healthcare
- HQ
- Nedlands, Australia
- Founded
- 2016
- Employees
- 40
- Website
- oncoresmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.